Product
pralatrexate
Aliases
FOLOTYN, PDX
2 clinical trials
6 indications
Indication
solid tumorIndication
Protocol SpecificIndication
Anaplastic Large Cell LymphomaIndication
Angioimmunoblastic T-cell LymphomaIndication
Hepatosplenic T-cell LymphomaIndication
Peripheral T-cell LymphomaClinical trial
A Phase I Clinical Trial of Sequential Pralatrexate Followed by a 48-hour Infusion of 5- Fluorouracil Given Every Other Week in Adult Patients With Solid TumorsStatus: Completed, Estimated PCD: 2015-02-04
Clinical trial
A Phase II Study of Cyclophosphamide, Etoposide, Vincristine and Prednisone (CEOP) Alternating With Pralatrexate (P) as Front Line Therapy for Patients With Stage II, III and IV Peripheral T-Cell Non-Hodgkin LymphomaStatus: Completed, Estimated PCD: 2016-12-28